Efficacy and Safety of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis of the Scalp
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study
J Am Acad Dermatol 2024 Mar 28;[EPub Ahead of Print], K Gebauer, L Spelman, PS Yamauchi, J Bagel, T Nishandar, M Crane, I Kopeloff, M Kothekar, SL Yao, HL SofenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.